MedTrace Logo

Anti-shivering Effect of Ondansetron

NCT03530007 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-05-21

No results posted yet for this study

Summary

Shivering is one of the most frequent complications occurring during or after spinal anesthesia with many side effects. The aim of the present study was to compare between two different doses of ondansetron for anti-shivering effect

Conditions

  • Shivering
  • Ondansetron

Interventions

DRUG

Normal saline

normal saline used for prevention of spinal shivering

DRUG

Ondansetron 4 MG

ondansetron 4 MG used for prevention of spinal shivering

DRUG

Ondansetron 8mg

ondansetron 8 MG used for prevention of spinal shivering

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2018-08-15
Completion
2018-09-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03530007 on ClinicalTrials.gov